Efficacy of topical corticosteroids in nickel-induced contact allergy
Summary In this study we used the nickel contact allergy patch (CAP) test to investigate the effect of topical corticosteroids on allergic contact dermatitis (ACD). On day 1, three CAP tests were applied for 48 h on the forearms of 20 female volunteers with a known nickel ACD. CAP of the right fore...
Gespeichert in:
Veröffentlicht in: | Clinical and experimental dermatology 2002-01, Vol.27 (1), p.47-50 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 50 |
---|---|
container_issue | 1 |
container_start_page | 47 |
container_title | Clinical and experimental dermatology |
container_volume | 27 |
creator | Hachem, J. P. De Paepe, K. Vanpée, E. Bogaerts, M. Kaufman, L. Rogiers, V. Roseeuw, D. |
description | Summary In this study we used the nickel contact allergy patch (CAP) test to investigate the effect of topical corticosteroids on allergic contact dermatitis (ACD). On day 1, three CAP tests were applied for 48 h on the forearms of 20 female volunteers with a known nickel ACD. CAP of the right forearm contained 5% nickel, and of the left forearm physiological saline. Clinical scoring, transepidermal water loss and skin hydration were measured on day 1 before CAP application, on day 4 (0, 2 and 6 h) after ACD and from days 5 to 8 (0 h). A topical corticosteroid and its vehicle were applied twice daily starting from day 4 on two ACD sites. Transepidermal water loss values were significantly decreased on the topical‐corticosteroid‐treated sites in the early phase of ACD (day 4, 6 h after the first application) while clinical efficacy showed significant improvement on days 7 and 8. The vehicle was found to improve skin hydration only on day 8. In conclusion the topical corticosteroid improved the skin barrier function in the early inflammatory phase of ACD (day 4, 6 h). The lack of improvement in transepidermal water loss in the later phase of ACD might be accounted for by the secondary effects of the corticosteroid on proliferation and differentiation of keratinocytes. |
doi_str_mv | 10.1046/j.0307-6938.2001.00963.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_journals_201304020</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>113026322</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4763-c790c8df441669dd039434118233758cfef1e97d5699398340ee735fbdf840273</originalsourceid><addsrcrecordid>eNpFkUlPwzAQhS0EgrL8BRQhcUwYZxw7lrhAWwoSy4XlaAUvyCUkxUlF--9xaYGTR_L3ZvTeIyShkFFg_GyaAYJIucQyywFoBiA5ZostMqDIizTPEbbJ4A_aI_tdN40gUlHskj1KZZFzAQMyHjvndaWXSeuSvp3FuU50G3qv2663ofWmS3yTNF6_2zr1jZlrayLR9JXuk6qubXhbHpIdV9WdPdq8B-Tpavw4vE5vHyY3w4vbVDPBMdVCgi6NY4xyLo0BlAwZpWWOKIpSO-uolcIUXEqUJTKwVmDhXo0rGeQCD8jJeu8stJ9z2_Vq2s5DE0-qPJqDCEGEjjfQ_PXDGjUL_qMKS_VrOgKnG6Dqol0Xqkb77p9DUYIULHLna-7L13b5_w9qVYKaqlW-apWvWpWgfkpQCzUcj-IQ5ela7mOQiz95Fd4VF9GvermfqMvr0eTumb8oid96U4b9</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>201304020</pqid></control><display><type>article</type><title>Efficacy of topical corticosteroids in nickel-induced contact allergy</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Hachem, J. P. ; De Paepe, K. ; Vanpée, E. ; Bogaerts, M. ; Kaufman, L. ; Rogiers, V. ; Roseeuw, D.</creator><creatorcontrib>Hachem, J. P. ; De Paepe, K. ; Vanpée, E. ; Bogaerts, M. ; Kaufman, L. ; Rogiers, V. ; Roseeuw, D.</creatorcontrib><description>Summary In this study we used the nickel contact allergy patch (CAP) test to investigate the effect of topical corticosteroids on allergic contact dermatitis (ACD). On day 1, three CAP tests were applied for 48 h on the forearms of 20 female volunteers with a known nickel ACD. CAP of the right forearm contained 5% nickel, and of the left forearm physiological saline. Clinical scoring, transepidermal water loss and skin hydration were measured on day 1 before CAP application, on day 4 (0, 2 and 6 h) after ACD and from days 5 to 8 (0 h). A topical corticosteroid and its vehicle were applied twice daily starting from day 4 on two ACD sites. Transepidermal water loss values were significantly decreased on the topical‐corticosteroid‐treated sites in the early phase of ACD (day 4, 6 h after the first application) while clinical efficacy showed significant improvement on days 7 and 8. The vehicle was found to improve skin hydration only on day 8. In conclusion the topical corticosteroid improved the skin barrier function in the early inflammatory phase of ACD (day 4, 6 h). The lack of improvement in transepidermal water loss in the later phase of ACD might be accounted for by the secondary effects of the corticosteroid on proliferation and differentiation of keratinocytes.</description><identifier>ISSN: 0307-6938</identifier><identifier>EISSN: 1365-2230</identifier><identifier>DOI: 10.1046/j.0307-6938.2001.00963.x</identifier><identifier>PMID: 11952670</identifier><identifier>CODEN: CEDEDE</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Science, Ltd</publisher><subject>Administration, Cutaneous ; Adult ; Allergic diseases ; Androstadienes - therapeutic use ; Anti-Inflammatory Agents - therapeutic use ; Biological and medical sciences ; Dermatitis, Allergic Contact - drug therapy ; Dermatitis, Allergic Contact - etiology ; Dermatitis, Allergic Contact - physiopathology ; Dermatologic Agents - therapeutic use ; Double-Blind Method ; Female ; Fluticasone ; Glucocorticoids ; Humans ; Immunopathology ; Medical sciences ; Nickel - adverse effects ; Patch Tests ; Pharmacology. Drug treatments ; Skin allergic diseases. Stinging insect allergies ; Skin, nail, hair, dermoskeleton ; Treatment Outcome ; Water Loss, Insensible - drug effects</subject><ispartof>Clinical and experimental dermatology, 2002-01, Vol.27 (1), p.47-50</ispartof><rights>2003 INIST-CNRS</rights><rights>Copyright Blackwell Science Ltd. Jan 2002</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4763-c790c8df441669dd039434118233758cfef1e97d5699398340ee735fbdf840273</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13780974$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11952670$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hachem, J. P.</creatorcontrib><creatorcontrib>De Paepe, K.</creatorcontrib><creatorcontrib>Vanpée, E.</creatorcontrib><creatorcontrib>Bogaerts, M.</creatorcontrib><creatorcontrib>Kaufman, L.</creatorcontrib><creatorcontrib>Rogiers, V.</creatorcontrib><creatorcontrib>Roseeuw, D.</creatorcontrib><title>Efficacy of topical corticosteroids in nickel-induced contact allergy</title><title>Clinical and experimental dermatology</title><addtitle>Clin Exp Dermatol</addtitle><description>Summary In this study we used the nickel contact allergy patch (CAP) test to investigate the effect of topical corticosteroids on allergic contact dermatitis (ACD). On day 1, three CAP tests were applied for 48 h on the forearms of 20 female volunteers with a known nickel ACD. CAP of the right forearm contained 5% nickel, and of the left forearm physiological saline. Clinical scoring, transepidermal water loss and skin hydration were measured on day 1 before CAP application, on day 4 (0, 2 and 6 h) after ACD and from days 5 to 8 (0 h). A topical corticosteroid and its vehicle were applied twice daily starting from day 4 on two ACD sites. Transepidermal water loss values were significantly decreased on the topical‐corticosteroid‐treated sites in the early phase of ACD (day 4, 6 h after the first application) while clinical efficacy showed significant improvement on days 7 and 8. The vehicle was found to improve skin hydration only on day 8. In conclusion the topical corticosteroid improved the skin barrier function in the early inflammatory phase of ACD (day 4, 6 h). The lack of improvement in transepidermal water loss in the later phase of ACD might be accounted for by the secondary effects of the corticosteroid on proliferation and differentiation of keratinocytes.</description><subject>Administration, Cutaneous</subject><subject>Adult</subject><subject>Allergic diseases</subject><subject>Androstadienes - therapeutic use</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Dermatitis, Allergic Contact - drug therapy</subject><subject>Dermatitis, Allergic Contact - etiology</subject><subject>Dermatitis, Allergic Contact - physiopathology</subject><subject>Dermatologic Agents - therapeutic use</subject><subject>Double-Blind Method</subject><subject>Female</subject><subject>Fluticasone</subject><subject>Glucocorticoids</subject><subject>Humans</subject><subject>Immunopathology</subject><subject>Medical sciences</subject><subject>Nickel - adverse effects</subject><subject>Patch Tests</subject><subject>Pharmacology. Drug treatments</subject><subject>Skin allergic diseases. Stinging insect allergies</subject><subject>Skin, nail, hair, dermoskeleton</subject><subject>Treatment Outcome</subject><subject>Water Loss, Insensible - drug effects</subject><issn>0307-6938</issn><issn>1365-2230</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkUlPwzAQhS0EgrL8BRQhcUwYZxw7lrhAWwoSy4XlaAUvyCUkxUlF--9xaYGTR_L3ZvTeIyShkFFg_GyaAYJIucQyywFoBiA5ZostMqDIizTPEbbJ4A_aI_tdN40gUlHskj1KZZFzAQMyHjvndaWXSeuSvp3FuU50G3qv2663ofWmS3yTNF6_2zr1jZlrayLR9JXuk6qubXhbHpIdV9WdPdq8B-Tpavw4vE5vHyY3w4vbVDPBMdVCgi6NY4xyLo0BlAwZpWWOKIpSO-uolcIUXEqUJTKwVmDhXo0rGeQCD8jJeu8stJ9z2_Vq2s5DE0-qPJqDCEGEjjfQ_PXDGjUL_qMKS_VrOgKnG6Dqol0Xqkb77p9DUYIULHLna-7L13b5_w9qVYKaqlW-apWvWpWgfkpQCzUcj-IQ5ela7mOQiz95Fd4VF9GvermfqMvr0eTumb8oid96U4b9</recordid><startdate>200201</startdate><enddate>200201</enddate><creator>Hachem, J. P.</creator><creator>De Paepe, K.</creator><creator>Vanpée, E.</creator><creator>Bogaerts, M.</creator><creator>Kaufman, L.</creator><creator>Rogiers, V.</creator><creator>Roseeuw, D.</creator><general>Blackwell Science, Ltd</general><general>Blackwell</general><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope></search><sort><creationdate>200201</creationdate><title>Efficacy of topical corticosteroids in nickel-induced contact allergy</title><author>Hachem, J. P. ; De Paepe, K. ; Vanpée, E. ; Bogaerts, M. ; Kaufman, L. ; Rogiers, V. ; Roseeuw, D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4763-c790c8df441669dd039434118233758cfef1e97d5699398340ee735fbdf840273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Administration, Cutaneous</topic><topic>Adult</topic><topic>Allergic diseases</topic><topic>Androstadienes - therapeutic use</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Dermatitis, Allergic Contact - drug therapy</topic><topic>Dermatitis, Allergic Contact - etiology</topic><topic>Dermatitis, Allergic Contact - physiopathology</topic><topic>Dermatologic Agents - therapeutic use</topic><topic>Double-Blind Method</topic><topic>Female</topic><topic>Fluticasone</topic><topic>Glucocorticoids</topic><topic>Humans</topic><topic>Immunopathology</topic><topic>Medical sciences</topic><topic>Nickel - adverse effects</topic><topic>Patch Tests</topic><topic>Pharmacology. Drug treatments</topic><topic>Skin allergic diseases. Stinging insect allergies</topic><topic>Skin, nail, hair, dermoskeleton</topic><topic>Treatment Outcome</topic><topic>Water Loss, Insensible - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hachem, J. P.</creatorcontrib><creatorcontrib>De Paepe, K.</creatorcontrib><creatorcontrib>Vanpée, E.</creatorcontrib><creatorcontrib>Bogaerts, M.</creatorcontrib><creatorcontrib>Kaufman, L.</creatorcontrib><creatorcontrib>Rogiers, V.</creatorcontrib><creatorcontrib>Roseeuw, D.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><jtitle>Clinical and experimental dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hachem, J. P.</au><au>De Paepe, K.</au><au>Vanpée, E.</au><au>Bogaerts, M.</au><au>Kaufman, L.</au><au>Rogiers, V.</au><au>Roseeuw, D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efficacy of topical corticosteroids in nickel-induced contact allergy</atitle><jtitle>Clinical and experimental dermatology</jtitle><addtitle>Clin Exp Dermatol</addtitle><date>2002-01</date><risdate>2002</risdate><volume>27</volume><issue>1</issue><spage>47</spage><epage>50</epage><pages>47-50</pages><issn>0307-6938</issn><eissn>1365-2230</eissn><coden>CEDEDE</coden><abstract>Summary In this study we used the nickel contact allergy patch (CAP) test to investigate the effect of topical corticosteroids on allergic contact dermatitis (ACD). On day 1, three CAP tests were applied for 48 h on the forearms of 20 female volunteers with a known nickel ACD. CAP of the right forearm contained 5% nickel, and of the left forearm physiological saline. Clinical scoring, transepidermal water loss and skin hydration were measured on day 1 before CAP application, on day 4 (0, 2 and 6 h) after ACD and from days 5 to 8 (0 h). A topical corticosteroid and its vehicle were applied twice daily starting from day 4 on two ACD sites. Transepidermal water loss values were significantly decreased on the topical‐corticosteroid‐treated sites in the early phase of ACD (day 4, 6 h after the first application) while clinical efficacy showed significant improvement on days 7 and 8. The vehicle was found to improve skin hydration only on day 8. In conclusion the topical corticosteroid improved the skin barrier function in the early inflammatory phase of ACD (day 4, 6 h). The lack of improvement in transepidermal water loss in the later phase of ACD might be accounted for by the secondary effects of the corticosteroid on proliferation and differentiation of keratinocytes.</abstract><cop>Oxford, UK</cop><pub>Blackwell Science, Ltd</pub><pmid>11952670</pmid><doi>10.1046/j.0307-6938.2001.00963.x</doi><tpages>4</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0307-6938 |
ispartof | Clinical and experimental dermatology, 2002-01, Vol.27 (1), p.47-50 |
issn | 0307-6938 1365-2230 |
language | eng |
recordid | cdi_proquest_journals_201304020 |
source | Oxford University Press Journals All Titles (1996-Current); MEDLINE; Alma/SFX Local Collection |
subjects | Administration, Cutaneous Adult Allergic diseases Androstadienes - therapeutic use Anti-Inflammatory Agents - therapeutic use Biological and medical sciences Dermatitis, Allergic Contact - drug therapy Dermatitis, Allergic Contact - etiology Dermatitis, Allergic Contact - physiopathology Dermatologic Agents - therapeutic use Double-Blind Method Female Fluticasone Glucocorticoids Humans Immunopathology Medical sciences Nickel - adverse effects Patch Tests Pharmacology. Drug treatments Skin allergic diseases. Stinging insect allergies Skin, nail, hair, dermoskeleton Treatment Outcome Water Loss, Insensible - drug effects |
title | Efficacy of topical corticosteroids in nickel-induced contact allergy |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T13%3A26%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efficacy%20of%20topical%20corticosteroids%20in%20nickel-induced%20contact%20allergy&rft.jtitle=Clinical%20and%20experimental%20dermatology&rft.au=Hachem,%20J.%20P.&rft.date=2002-01&rft.volume=27&rft.issue=1&rft.spage=47&rft.epage=50&rft.pages=47-50&rft.issn=0307-6938&rft.eissn=1365-2230&rft.coden=CEDEDE&rft_id=info:doi/10.1046/j.0307-6938.2001.00963.x&rft_dat=%3Cproquest_pubme%3E113026322%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=201304020&rft_id=info:pmid/11952670&rfr_iscdi=true |